BioCentury
ARTICLE | Company News

Oncolytics to conduct pilot study of oncolytic virus with SOLTI

September 14, 2018 7:15 PM UTC

Oncolytics Biotech Inc. (TSX:ONC; NASDAQ:ONCY) partnered with the non-profit group SOLTI (Barcelona, Spain) to conduct a pilot study of the biotech's Reolysin pelareorep in the neoadjuvant setting for breast cancer. SOLTI will facilitate the trial, which will be sponsored by Oncolytics.

Reolysin is a formulation of human reovirus type 3, an oncolytic virus...

BCIQ Company Profiles

Oncolytics Biotech Inc.